PDCD1LG2 and Miyoshi myopathy: Important immune checkpoint ligands, including GAL9, ICOSL, HLA‐DR, CD86, PD‐L2, and 4‐1BBL, were expressed by more than 10% of MM cells in average (Figure 1f and Supplementary figure 1b).